EFFICACY AND SAFETY OF GUSELKUMAB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS OF THE GALAXI 2 G 3 PHASE 3 STUDIESRemo Panaccione,Silvio Danese,Brian G. Feagan,Geert D'Haens,Anita Afzali,Walter Reinisch,Julian Panes,David T. Rubin,Jane M. Andrews,Tadakazu Hisamatsu,Natalie A. Terry,Leonardo Salese,Rian Van Rampelbergh,Mary Ellen S. Frustaci,Zijiang Yang,Jewel Johanns, Kitty Y. Wan, Jacqueline Yee,Bruce E. SandsGASTROENTEROLOGY(2024)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要